Global Infectious Vaccines Market Growth 2023-2028

Report ID: 1504334 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Infectious Vaccines Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Infectious Vaccines by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Infectious Vaccines by Country/Region, 2017, 2022 & 2028
    2.2 Infectious Vaccines Segment by Type
        2.2.1 Preventive Vaccine
        2.2.2 Therapeutic Vaccine
    2.3 Infectious Vaccines Sales by Type
        2.3.1 Global Infectious Vaccines Sales Market Share by Type (2017-2022)
        2.3.2 Global Infectious Vaccines Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Infectious Vaccines Sale Price by Type (2017-2022)
    2.4 Infectious Vaccines Segment by Application
        2.4.1 Adults
        2.4.2 Pediatrics
    2.5 Infectious Vaccines Sales by Application
        2.5.1 Global Infectious Vaccines Sale Market Share by Application (2017-2022)
        2.5.2 Global Infectious Vaccines Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Infectious Vaccines Sale Price by Application (2017-2022)
3 Global Infectious Vaccines by Company
    3.1 Global Infectious Vaccines Breakdown Data by Company
        3.1.1 Global Infectious Vaccines Annual Sales by Company (2020-2022)
        3.1.2 Global Infectious Vaccines Sales Market Share by Company (2020-2022)
    3.2 Global Infectious Vaccines Annual Revenue by Company (2020-2022)
        3.2.1 Global Infectious Vaccines Revenue by Company (2020-2022)
        3.2.2 Global Infectious Vaccines Revenue Market Share by Company (2020-2022)
    3.3 Global Infectious Vaccines Sale Price by Company
    3.4 Key Manufacturers Infectious Vaccines Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Infectious Vaccines Product Location Distribution
        3.4.2 Players Infectious Vaccines Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Infectious Vaccines by Geographic Region
    4.1 World Historic Infectious Vaccines Market Size by Geographic Region (2017-2022)
        4.1.1 Global Infectious Vaccines Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Infectious Vaccines Annual Revenue by Geographic Region
    4.2 World Historic Infectious Vaccines Market Size by Country/Region (2017-2022)
        4.2.1 Global Infectious Vaccines Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Infectious Vaccines Annual Revenue by Country/Region
    4.3 Americas Infectious Vaccines Sales Growth
    4.4 APAC Infectious Vaccines Sales Growth
    4.5 Europe Infectious Vaccines Sales Growth
    4.6 Middle East & Africa Infectious Vaccines Sales Growth
5 Americas
    5.1 Americas Infectious Vaccines Sales by Country
        5.1.1 Americas Infectious Vaccines Sales by Country (2017-2022)
        5.1.2 Americas Infectious Vaccines Revenue by Country (2017-2022)
    5.2 Americas Infectious Vaccines Sales by Type
    5.3 Americas Infectious Vaccines Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Infectious Vaccines Sales by Region
        6.1.1 APAC Infectious Vaccines Sales by Region (2017-2022)
        6.1.2 APAC Infectious Vaccines Revenue by Region (2017-2022)
    6.2 APAC Infectious Vaccines Sales by Type
    6.3 APAC Infectious Vaccines Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Infectious Vaccines by Country
        7.1.1 Europe Infectious Vaccines Sales by Country (2017-2022)
        7.1.2 Europe Infectious Vaccines Revenue by Country (2017-2022)
    7.2 Europe Infectious Vaccines Sales by Type
    7.3 Europe Infectious Vaccines Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Infectious Vaccines by Country
        8.1.1 Middle East & Africa Infectious Vaccines Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Infectious Vaccines Revenue by Country (2017-2022)
    8.2 Middle East & Africa Infectious Vaccines Sales by Type
    8.3 Middle East & Africa Infectious Vaccines Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Infectious Vaccines
    10.3 Manufacturing Process Analysis of Infectious Vaccines
    10.4 Industry Chain Structure of Infectious Vaccines
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Infectious Vaccines Distributors
    11.3 Infectious Vaccines Customer
12 World Forecast Review for Infectious Vaccines by Geographic Region
    12.1 Global Infectious Vaccines Market Size Forecast by Region
        12.1.1 Global Infectious Vaccines Forecast by Region (2023-2028)
        12.1.2 Global Infectious Vaccines Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Infectious Vaccines Forecast by Type
    12.7 Global Infectious Vaccines Forecast by Application
13 Key Players Analysis
    13.1 CSL Limited (Australia)
        13.1.1 CSL Limited (Australia) Company Information
        13.1.2 CSL Limited (Australia) Infectious Vaccines Product Offered
        13.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 CSL Limited (Australia) Main Business Overview
        13.1.5 CSL Limited (Australia) Latest Developments
    13.2 Bavarian Nordic (Denmark)
        13.2.1 Bavarian Nordic (Denmark) Company Information
        13.2.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Offered
        13.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Bavarian Nordic (Denmark) Main Business Overview
        13.2.5 Bavarian Nordic (Denmark) Latest Developments
    13.3 GlaxoSmithKline plc. (U.K.)
        13.3.1 GlaxoSmithKline plc. (U.K.) Company Information
        13.3.2 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Offered
        13.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GlaxoSmithKline plc. (U.K.) Main Business Overview
        13.3.5 GlaxoSmithKline plc. (U.K.) Latest Developments
    13.4 Emergent Bio Solutions Inc. (U.S.)
        13.4.1 Emergent Bio Solutions Inc. (U.S.) Company Information
        13.4.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Offered
        13.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Emergent Bio Solutions Inc. (U.S.) Main Business Overview
        13.4.5 Emergent Bio Solutions Inc. (U.S.) Latest Developments
    13.5 MedImmune LLC (U.S.)
        13.5.1 MedImmune LLC (U.S.) Company Information
        13.5.2 MedImmune LLC (U.S.) Infectious Vaccines Product Offered
        13.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 MedImmune LLC (U.S.) Main Business Overview
        13.5.5 MedImmune LLC (U.S.) Latest Developments
    13.6 Johnson and Johnson (U.S.)
        13.6.1 Johnson and Johnson (U.S.) Company Information
        13.6.2 Johnson and Johnson (U.S.) Infectious Vaccines Product Offered
        13.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Johnson and Johnson (U.S.) Main Business Overview
        13.6.5 Johnson and Johnson (U.S.) Latest Developments
    13.7 Novartis AG (Switzerland)
        13.7.1 Novartis AG (Switzerland) Company Information
        13.7.2 Novartis AG (Switzerland) Infectious Vaccines Product Offered
        13.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Novartis AG (Switzerland) Main Business Overview
        13.7.5 Novartis AG (Switzerland) Latest Developments
    13.8 Merck and Company (U.S.)
        13.8.1 Merck and Company (U.S.) Company Information
        13.8.2 Merck and Company (U.S.) Infectious Vaccines Product Offered
        13.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Merck and Company (U.S.) Main Business Overview
        13.8.5 Merck and Company (U.S.) Latest Developments
    13.9 Sanofi Pasteur (France)
        13.9.1 Sanofi Pasteur (France) Company Information
        13.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Offered
        13.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Sanofi Pasteur (France) Main Business Overview
        13.9.5 Sanofi Pasteur (France) Latest Developments
    13.10 Pfizer Inc. (U.S.)
        13.10.1 Pfizer Inc. (U.S.) Company Information
        13.10.2 Pfizer Inc. (U.S.) Infectious Vaccines Product Offered
        13.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Pfizer Inc. (U.S.) Main Business Overview
        13.10.5 Pfizer Inc. (U.S.) Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Infectious Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Infectious Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Preventive Vaccine
    Table 4. Major Players of Therapeutic Vaccine
    Table 5. Global Infectious Vaccines Sales by Type (2017-2022) & (K Units)
    Table 6. Global Infectious Vaccines Sales Market Share by Type (2017-2022)
    Table 7. Global Infectious Vaccines Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Infectious Vaccines Revenue Market Share by Type (2017-2022)
    Table 9. Global Infectious Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Infectious Vaccines Sales by Application (2017-2022) & (K Units)
    Table 11. Global Infectious Vaccines Sales Market Share by Application (2017-2022)
    Table 12. Global Infectious Vaccines Revenue by Application (2017-2022)
    Table 13. Global Infectious Vaccines Revenue Market Share by Application (2017-2022)
    Table 14. Global Infectious Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Infectious Vaccines Sales by Company (2020-2022) & (K Units)
    Table 16. Global Infectious Vaccines Sales Market Share by Company (2020-2022)
    Table 17. Global Infectious Vaccines Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Infectious Vaccines Revenue Market Share by Company (2020-2022)
    Table 19. Global Infectious Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Infectious Vaccines Producing Area Distribution and Sales Area
    Table 21. Players Infectious Vaccines Products Offered
    Table 22. Infectious Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Infectious Vaccines Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Infectious Vaccines Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Infectious Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Infectious Vaccines Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Infectious Vaccines Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Infectious Vaccines Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Infectious Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Infectious Vaccines Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Infectious Vaccines Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Infectious Vaccines Sales Market Share by Country (2017-2022)
    Table 35. Americas Infectious Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Infectious Vaccines Revenue Market Share by Country (2017-2022)
    Table 37. Americas Infectious Vaccines Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Infectious Vaccines Sales Market Share by Type (2017-2022)
    Table 39. Americas Infectious Vaccines Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Infectious Vaccines Sales Market Share by Application (2017-2022)
    Table 41. APAC Infectious Vaccines Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Infectious Vaccines Sales Market Share by Region (2017-2022)
    Table 43. APAC Infectious Vaccines Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Infectious Vaccines Revenue Market Share by Region (2017-2022)
    Table 45. APAC Infectious Vaccines Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Infectious Vaccines Sales Market Share by Type (2017-2022)
    Table 47. APAC Infectious Vaccines Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Infectious Vaccines Sales Market Share by Application (2017-2022)
    Table 49. Europe Infectious Vaccines Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Infectious Vaccines Sales Market Share by Country (2017-2022)
    Table 51. Europe Infectious Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Infectious Vaccines Revenue Market Share by Country (2017-2022)
    Table 53. Europe Infectious Vaccines Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Infectious Vaccines Sales Market Share by Type (2017-2022)
    Table 55. Europe Infectious Vaccines Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Infectious Vaccines Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Infectious Vaccines Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Infectious Vaccines Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Infectious Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Infectious Vaccines Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Infectious Vaccines Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Infectious Vaccines Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Infectious Vaccines Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Infectious Vaccines Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Infectious Vaccines
    Table 66. Key Market Challenges & Risks of Infectious Vaccines
    Table 67. Key Industry Trends of Infectious Vaccines
    Table 68. Infectious Vaccines Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Infectious Vaccines Distributors List
    Table 71. Infectious Vaccines Customer List
    Table 72. Global Infectious Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Infectious Vaccines Sales Market Forecast by Region
    Table 74. Global Infectious Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Infectious Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Infectious Vaccines Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Infectious Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Infectious Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Infectious Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Infectious Vaccines Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Infectious Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Infectious Vaccines Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Infectious Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Infectious Vaccines Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Infectious Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Infectious Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Infectious Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Infectious Vaccines Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Infectious Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Infectious Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Infectious Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 92. CSL Limited (Australia) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 93. CSL Limited (Australia) Infectious Vaccines Product Offered
    Table 94. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. CSL Limited (Australia) Main Business
    Table 96. CSL Limited (Australia) Latest Developments
    Table 97. Bavarian Nordic (Denmark) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 98. Bavarian Nordic (Denmark) Infectious Vaccines Product Offered
    Table 99. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Bavarian Nordic (Denmark) Main Business
    Table 101. Bavarian Nordic (Denmark) Latest Developments
    Table 102. GlaxoSmithKline plc. (U.K.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 103. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Offered
    Table 104. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. GlaxoSmithKline plc. (U.K.) Main Business
    Table 106. GlaxoSmithKline plc. (U.K.) Latest Developments
    Table 107. Emergent Bio Solutions Inc. (U.S.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 108. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Offered
    Table 109. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Emergent Bio Solutions Inc. (U.S.) Main Business
    Table 111. Emergent Bio Solutions Inc. (U.S.) Latest Developments
    Table 112. MedImmune LLC (U.S.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 113. MedImmune LLC (U.S.) Infectious Vaccines Product Offered
    Table 114. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 115. MedImmune LLC (U.S.) Main Business
    Table 116. MedImmune LLC (U.S.) Latest Developments
    Table 117. Johnson and Johnson (U.S.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 118. Johnson and Johnson (U.S.) Infectious Vaccines Product Offered
    Table 119. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 120. Johnson and Johnson (U.S.) Main Business
    Table 121. Johnson and Johnson (U.S.) Latest Developments
    Table 122. Novartis AG (Switzerland) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 123. Novartis AG (Switzerland) Infectious Vaccines Product Offered
    Table 124. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 125. Novartis AG (Switzerland) Main Business
    Table 126. Novartis AG (Switzerland) Latest Developments
    Table 127. Merck and Company (U.S.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 128. Merck and Company (U.S.) Infectious Vaccines Product Offered
    Table 129. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 130. Merck and Company (U.S.) Main Business
    Table 131. Merck and Company (U.S.) Latest Developments
    Table 132. Sanofi Pasteur (France) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 133. Sanofi Pasteur (France) Infectious Vaccines Product Offered
    Table 134. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 135. Sanofi Pasteur (France) Main Business
    Table 136. Sanofi Pasteur (France) Latest Developments
    Table 137. Pfizer Inc. (U.S.) Basic Information, Infectious Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 138. Pfizer Inc. (U.S.) Infectious Vaccines Product Offered
    Table 139. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 140. Pfizer Inc. (U.S.) Main Business
    Table 141. Pfizer Inc. (U.S.) Latest Developments
List of Figures
    Figure 1. Picture of Infectious Vaccines
    Figure 2. Infectious Vaccines Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Infectious Vaccines Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Infectious Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Infectious Vaccines Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Preventive Vaccine
    Figure 10. Product Picture of Therapeutic Vaccine
    Figure 11. Global Infectious Vaccines Sales Market Share by Type in 2021
    Figure 12. Global Infectious Vaccines Revenue Market Share by Type (2017-2022)
    Figure 13. Infectious Vaccines Consumed in Adults
    Figure 14. Global Infectious Vaccines Market: Adults (2017-2022) & (K Units)
    Figure 15. Infectious Vaccines Consumed in Pediatrics
    Figure 16. Global Infectious Vaccines Market: Pediatrics (2017-2022) & (K Units)
    Figure 17. Global Infectious Vaccines Sales Market Share by Application (2017-2022)
    Figure 18. Global Infectious Vaccines Revenue Market Share by Application in 2021
    Figure 19. Infectious Vaccines Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Infectious Vaccines Revenue Market Share by Company in 2021
    Figure 21. Global Infectious Vaccines Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Infectious Vaccines Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Infectious Vaccines Sales Market Share by Region (2017-2022)
    Figure 24. Global Infectious Vaccines Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Infectious Vaccines Sales 2017-2022 (K Units)
    Figure 26. Americas Infectious Vaccines Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Infectious Vaccines Sales 2017-2022 (K Units)
    Figure 28. APAC Infectious Vaccines Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Infectious Vaccines Sales 2017-2022 (K Units)
    Figure 30. Europe Infectious Vaccines Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Infectious Vaccines Sales 2017-2022 (K Units)
    Figure 32. Middle East & Africa Infectious Vaccines Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Infectious Vaccines Sales Market Share by Country in 2021
    Figure 34. Americas Infectious Vaccines Revenue Market Share by Country in 2021
    Figure 35. United States Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Infectious Vaccines Sales Market Share by Region in 2021
    Figure 40. APAC Infectious Vaccines Revenue Market Share by Regions in 2021
    Figure 41. China Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Infectious Vaccines Sales Market Share by Country in 2021
    Figure 48. Europe Infectious Vaccines Revenue Market Share by Country in 2021
    Figure 49. Germany Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Infectious Vaccines Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Infectious Vaccines Revenue Market Share by Country in 2021
    Figure 56. Egypt Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Infectious Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Infectious Vaccines in 2021
    Figure 62. Manufacturing Process Analysis of Infectious Vaccines
    Figure 63. Industry Chain Structure of Infectious Vaccines
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Infectious Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Infectious Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Infectious Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports